Changes in Health ‐Related Quality of Life with Long‐term Eltrombopag Treatment in Adults with Persistent/Chronic Immune Thrombocytopenia: Findings from the EXTEND Study

In conclusion, in addition to eltrombopag increasing platelet counts and reducing bleeding/bruising, it also alleviated fatigue, concerns about bleeding and bruising, and improved physical function in many patients, especially responders.This article is protected by copyright. All rights reserved.

Source: American Journal of Hematology - November 12, 2018 Category: Hematology Authors: Abderrahim Khelif, Mansoor N Saleh, Abdulgabar Salama, Maria do Socorro O. Portella, Mei Sheng Duh, Jasmina Ivanova, Kelly Grotzinger, Anuja N Roy, James B Bussel Tags: RESEARCH ARTICLE Source Type: research